Atrium Therapeutics, Inc. Common Stock (RNA) is a biotechnology company listed on NASDAQ.
Latest reported RNA revenue for 2026-06-30 was $22.6M. Net income was -$36.8M. Revenue was up 15.3% from 2026-03-31 to 2026-06-30. RNA currently screens at market cap $217.5M.
Use this RNA page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the RNA quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the RNA SEC filings page. Lician reads the product cache first so this HTML stays unique to Atrium Therapeutics, Inc. Common Stock even when a live quote feed is slow.
Latest cached year on this hub. Full RNA income, balance, and cash tables.